DYNE THERAPEUTICS, INC. (DYN)
COMFORT SYSTEMS USA INC (FIX)
Comfort Systems USA Announces First Quarter 2026 Conference Call and Webcast
4D MOLECULAR THERAPEUTICS, INC. (FDMT)
4DMT Announces New Employment Inducement Grants
GOODRX HOLDINGS, INC. (GDRX)
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
COREWEAVE, INC. (CRWV)
CoreWeave Announces Date of First Quarter 2026 Financial Results and Conference Call
PYXIS ONCOLOGY, INC. (PYXS)
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
SEALSQ CORP (LAES)
SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders
TALEN ENERGY CORP (TLN)
Talen Energy Announces Pricing of Senior Notes
CAMP4 THERAPEUTICS CORP (CAMP)
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PARAMOUNT SKYDANCE CORP (PSKY)
Paramount Declares Quarterly Cash Dividend
THERIVA BIOLOGICS, INC. (TOVX)
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
SAVARA INC (SVRA)
Savara Announces New Employment Inducement Grant
ORIC PHARMACEUTICALS, INC. (ORIC)
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting
VERA BRADLEY, INC. (VRA)
Vera Bradley Terminates Existing Shareholder Rights Plan